NF2 Avastin Tumour responses

• Research type

  Research Study

• Full title

  Neurofibromatosis type 2 associated tumours: clinical and radiological response to Bevacizumab (Avastin) in patients being treated for rapidly growing vestibular schwannoma.

• IRAS ID

  137776

• Contact name

  Allyson Parry

• Contact email

  allyson.parry@ouh.nhs.uk

• Sponsor organisation

  Oxford University Hospitals NHS Foundation Trust

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  13/LO/1316

• Date of REC Opinion

  2 Sep 2013

• REC opinion

  Favourable Opinion